← Back to Clinical Trials
Recruiting NCT06435234

NCT06435234 Construction of a Risky Sexual Behaviour Intervention Programme for College Students Based on BCW Theory

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06435234
Status Recruiting
Phase
Sponsor Rong Zhang
Condition Unsafe Sex
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-09-29
Primary Completion 2024-12

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age 24 Years
Study Type INTERVENTIONAL
Interventions
risky sexual behavior intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2024-09-29 with a primary completion date of 2024-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Using the intervention functions of Behavior Change Wheel (BCW) and BCTs, we constructed an intervention program for college students' risky sexual behaviors by combining literature analysis, qualitative research, Delphi's expert correspondence, and pre-experiment (20 students in the test group and 20 students in the control group). Before the intervention (T0) and at the end of the intervention (12 weeks, T1), we measured students' psychosexual health, social support, and sexual self-efficacy using relevant scales to ensure the effectiveness of the intervention. By clarifying the influencing factors of college students' risky sexual behaviors, the proposed intervention program for college students' risky sexual behaviors can effectively reduce the incidence of college students' risky sexual behaviors, improve the level of college students' psychosexual health, increase the level of social support, improve the sense of sexual self-efficacy, improve the level of risk perception, enhance the ability of risky decision-making, reduce the risky behaviors, and reduce the occurrence of adverse outcomes, thus providing a reference and reference for the prevention and control of college students' risky sexual behaviors. This will provide reference for the prevention and control of risky sexual behaviors among college students.

Eligibility Criteria

Inclusion Criteria: 1. aged ≥16 years; 2. full-time undergraduate college students; 3. engaged in risky sexual behaviors (including multiple sexual partners, unprotected sex, and casual sex, and one of them is considered to have engaged in risky sexual behaviors) during their college years; 4. able to clearly recall and describe the incident; 5. signed an informed consent form Exclusion Criteria: 1. not wanting to be asked sex-related questions; 2. being screened at the beginning of the semester using the Mental Health Survey and diagnosed by a psychiatrist as having a mental illness (schizophrenia, major depressive disorder, bipolar disorder)

Contact & Investigator

Central Contact

rong Z zhang, bachelor

✉ zhangrong15576@163.com

📞 15209929032

Frequently Asked Questions

Who can join the NCT06435234 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, up to 24 Years, studying Unsafe Sex. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06435234 currently recruiting?

Yes, NCT06435234 is actively recruiting participants. Contact the research team at zhangrong15576@163.com for enrollment information.

Where is the NCT06435234 trial being conducted?

This trial is being conducted at Daqing, China.

Who is sponsoring the NCT06435234 clinical trial?

NCT06435234 is sponsored by Rong Zhang. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology